ZyVersa Therapeutics (ZVSA) AGM 2024 summary

Opening remarks and agenda

• Meeting called to order by CEO, held virtually to maximize shareholder participation.

• Business portion conducted first, with Q&A scheduled for the end if time permits.

• Voting instructions provided, with polls opened at the start of the meeting.

Board and executive committee updates

• Board members and their committee roles introduced, including Compensation, Audit, and Nominating and Corporate Governance Committees.

• Management team introduced, including CFO, Chief Medical Officer, and Chief Commercial Officer.

Shareholder proposals

• Four proposals presented: election of a Class II Director, ratification of the independent auditor, amendment to the equity incentive plan, and approval of share issuance upon warrant exercise.